Using CRISPR-Cas9 we deleted PHGDH (Fig. 2a) in HCT116 and DLD-1 colorectal cancer cells (Fig. 2b and Extended Data Fig. 2a). This evidence concerns the gene PHGDH and colorectal cancer.